Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive metformin for recurrence prevention in non-diabetic high-risk stage II/III colorectal cancer
KCT0004236Phase 2Recruiting
- Sponsor
- Yonsei University Health System
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in colorectal cancer (CRC), sponsored by Yonsei University Health System. Started Jul 2016; status: recruiting.
02
Drugs
metformin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on KCT0004236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004236.